At a glance
- Originator Kaken Pharmaceutical
- Class Antihistamines; Antiulcers; Small molecules
- Mechanism of Action Histamine H2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastritis; Peptic ulcer
Most Recent Events
- 02 Oct 2001 No-Development-Reported for Gastritis in Japan (Unknown route)
- 02 Oct 2001 No-Development-Reported for Peptic ulcer in Japan (Unknown route)
- 21 Jun 1999 KP 105 is available for licensing (http://www.kaken.co.jp)